Skip to main content
Clinical Trials/NCT00021840
NCT00021840
Completed
Not Applicable

Genetic Epidemiology of Asthma in Costa Rica

Brigham and Women's Hospital1 site in 1 country4,245 target enrollmentJuly 2001

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Asthma
Sponsor
Brigham and Women's Hospital
Enrollment
4245
Locations
1
Primary Endpoint
Asthma diagnosis and asthma morbidity
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

To identify genetic factors that influence the development of asthma in Hispanics.

Detailed Description

BACKGROUND: Asthma is a major public health problem in the United States, with particularly high prevalence rates among some Hispanic groups. Genetic linkage studies of this disease are of potentially great utility for the identification of those at risk, the search for new pharmaceutical treatments, and designing interventions to prevent development of asthma. Study power is greatly enhanced if a relatively isolated, homogeneous population with a significant prevalence of asthma can be identified. Such a population does not exist among Hispanics in the United States but is available in the Central Valley of Costa Rica. DESIGN NARRATIVE: The study concentrates on a genetically isolated Hispanic population with high asthma prevalence living in the Central Valley of Costa Rica. A genome screen will be conducted on large pedigrees multiplex for asthma and linkage analysis performed for seven intermediate phenotypes related to asthma including airway responsiveness; FEV1; bronchodilator responsiveness; skin test reactivity to common aeroallergens; serum total and allergen-specific IgE; and peripheral blood eosinophil count. A genome screen will also be conducted in the parent-child trios, and ancestral haplotypes will be reconstructed to identify regions influencing asthma-associated phenotypes. Within candidate regions demonstrating both linkage in extended pedigrees to asthma and/or asthma-related phenotypes and significant linkage disequilibrium within the unrelated asthmatic subjects, fine mapping will be performed by testing for genetic association to single nucleotide polymorphisms within positional candidate genes.

Registry
clinicaltrials.gov
Start Date
July 2001
End Date
July 2011
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Scott T. Weiss

Professor of Medicine

Brigham and Women's Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Asthma diagnosis and asthma morbidity

Time Frame: Baseline/entry to study

Secondary Outcomes

  • Lung function measures(11 years)

Study Sites (1)

Loading locations...

Similar Trials